Linde Forecast, price target & analysts
Linde Target price 2026 - Analyst rating & recommendation
Linde Classifications & Recommendation
Linde Price Target
| Target Price | $561.00 |
| Price | $515.25 |
| Potential | 8.88% |
| Number of Estimates | 29 |
| 29 Analysts have issued a price target Linde 2027 . The average Linde target price is $561.00. This is 8.88% higher than the current stock price. The highest price target is $609.00 18.20% , the lowest is $404.00 21.59% . | |
| A rating was issued by 34 analysts: 24 Analysts recommend Linde to buy, 8 to hold and 2 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Linde stock has an average upside potential 2027 of 8.88% . Most analysts recommend the Linde stock at Purchase. |
Sales and Margin forecast 2026, 2027 to 2033
30 Analysts have issued a sales forecast Linde 2026 . The average Linde sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
27 Analysts have issued an Linde EBITDA forecast 2026. The average Linde EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
33 Linde Analysts have issued a net profit forecast 2026. The average Linde net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2033
Current Linde Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Buy
➜
Buy
|
Unchanged | Oct 30 2026 |
| Barclays |
Overweight
➜
Overweight
|
Unchanged | Oct 30 2026 |
| Citigroup |
Buy
➜
Buy
|
Unchanged | Oct 30 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 30 2026 |
| Keybanc |
Overweight
➜
Overweight
|
Unchanged | Oct 30 2026 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 15 2026 |
| Barclays |
➜
Overweight
|
Initiated | Oct 13 2026 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
UBS:
Buy
➜
Buy
|
Oct 30 2026 |
|
Unchanged
Barclays:
Overweight
➜
Overweight
|
Oct 30 2026 |
|
Unchanged
Citigroup:
Buy
➜
Buy
|
Oct 30 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 30 2026 |
|
Unchanged
Keybanc:
Overweight
➜
Overweight
|
Oct 30 2026 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 15 2026 |
|
Initiated
Barclays:
➜
Overweight
|
Oct 13 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
